Shandong Danhong Pharmaceutical

Shandong Danhong Pharmaceutical is a prominent Chinese pharmaceutical company and a core subsidiary of Shandong Buchang Pharmaceutical Co., Ltd. The company is primarily recognized for its expertise in the modernization of Traditional Chinese Medicine (TCM), specifically focusing on cardiovascular and cerebrovascular health. Its flagship product, Danhong Injection, is a widely utilized clinical treatment in China for conditions such as coronary heart disease and ischemic stroke. Operating out of large-scale, GMP-certified facilities in Shandong Province, the company integrates traditional herbal knowledge with modern pharmacological research. Shandong Danhong Pharmaceutical plays a critical role in the parent company's supply chain, handling high-volume production of botanical extracts and sterile injections.